Company attributes
Location
No article content yet.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
iPSirius
iPSirius SAS is an immuno-oncology firm focused on developing IPVAC 1.0, a novel therapeutic cancer vaccine. Leveraging the antigenic overlap between iPSCs and cancer stem cells (CSCs), iPSirius aims to combat relapse and metastatic progression in cancer patients.
Find more companies like iPSirius
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.